190 related articles for article (PubMed ID: 21696712)
21. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.
Howard LM; Miga AJ; Vanderlugt CL; Dal Canto MC; Laman JD; Noelle RJ; Miller SD
J Clin Invest; 1999 Jan; 103(2):281-90. PubMed ID: 9916140
[TBL] [Abstract][Full Text] [Related]
22. Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis.
Wegmann KW; Archie Bouwer HG; Whitham RH; Hinrichs DJ
J Neuroimmunol; 2014 Sep; 274(1-2):46-52. PubMed ID: 24997489
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.
Karpus WJ; Kennedy KJ; Smith WS; Miller SD
J Neurosci Res; 1996 Aug; 45(4):410-23. PubMed ID: 8872901
[TBL] [Abstract][Full Text] [Related]
24. Neonatal induction of myelin-specific Th1/Th17 immunity does not result in experimental autoimmune encephalomyelitis and can protect against the disease in adulthood.
Hofstetter HH; Kovalovsky A; Shive CL; Lehmann PV; Forsthuber TG
J Neuroimmunol; 2007 Jul; 187(1-2):20-30. PubMed ID: 17482277
[TBL] [Abstract][Full Text] [Related]
25. Determinant-regulated onset of experimental autoimmune encephalomyelitis: distinct epitopes of myelin proteolipid protein mediate either acute or delayed disease in SJL/J mice.
Tuohy VK; Thomas DM; Haqqi T; Yu M; Johnson JM
Autoimmunity; 1995; 21(3):203-14. PubMed ID: 8822278
[TBL] [Abstract][Full Text] [Related]
26. Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation.
Esposito M; Ruffini F; Bellone M; Gagliani N; Battaglia M; Martino G; Furlan R
J Neuroimmunol; 2010 Mar; 220(1-2):52-63. PubMed ID: 20149931
[TBL] [Abstract][Full Text] [Related]
27. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells.
Han D; Tian Y; Zhang M; Zhou Z; Lu J
Gene Ther; 2007 Mar; 14(5):383-95. PubMed ID: 17066098
[TBL] [Abstract][Full Text] [Related]
28. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
Xie C; Ciric B; Yu S; Zhang GX; Rostami A
J Neuroimmunol; 2016 Feb; 291():59-69. PubMed ID: 26857496
[TBL] [Abstract][Full Text] [Related]
29. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G
Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436
[TBL] [Abstract][Full Text] [Related]
30. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
Krakowski ML; Owens T
Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808
[TBL] [Abstract][Full Text] [Related]
31. Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα.
Nuro-Gyina PK; Rieser EL; Granitto MC; Pei W; Liu Y; Lee PW; Aqel S; Zhang J; Lovett-Racke AE; Racke MK; Yang Y
J Neuroinflammation; 2016 Dec; 13(1):302. PubMed ID: 27912762
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
33. Homotaurine limits the spreading of T cell autoreactivity within the CNS and ameliorates disease in a model of multiple sclerosis.
Tian J; Song M; Kaufman DL
Sci Rep; 2021 Mar; 11(1):5402. PubMed ID: 33686135
[TBL] [Abstract][Full Text] [Related]
34. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice.
Tuohy VK; Thomas DM
J Neuroimmunol; 1995 Feb; 56(2):161-70. PubMed ID: 7532182
[TBL] [Abstract][Full Text] [Related]
35. A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE.
Offner H; Zamora A; Drought H; Matejuk A; Auci DL; Morgan EE; Vandenbark AA; Reading CL
J Neuroimmunol; 2002 Sep; 130(1-2):128-39. PubMed ID: 12225895
[TBL] [Abstract][Full Text] [Related]
36. Functional maturation of proteolipid protein(139-151)-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitis.
Mohindru M; Kang B; Kim BS
J Neuroimmunol; 2004 Oct; 155(1-2):127-35. PubMed ID: 15342203
[TBL] [Abstract][Full Text] [Related]
37. Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151.
Zhang B; Harness J; Somodevilla-Torres MJ; Hillyard NC; Mould AW; Alewood D; Love SG; Alewood PF; Greer JM; Cavanagh AC; McCombe PA; Morton H
J Neurol Sci; 2000 Dec; 182(1):5-15. PubMed ID: 11102634
[TBL] [Abstract][Full Text] [Related]
38. Prevention of murine EAE by oral hydrolytic enzyme treatment.
Targoni OS; Tary-Lehmann M; Lehmann PV
J Autoimmun; 1999 May; 12(3):191-8. PubMed ID: 10222028
[TBL] [Abstract][Full Text] [Related]
39. RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS.
Sinha S; Miller LM; Subramanian S; Burrows GG; Vandenbark AA; Offner H
PLoS One; 2011; 6(7):e21868. PubMed ID: 21750737
[TBL] [Abstract][Full Text] [Related]
40. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
Kobayashi N; Kobayashi H; Gu L; Malefyt T; Siahaan TJ
J Pharmacol Exp Ther; 2007 Aug; 322(2):879-86. PubMed ID: 17522343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
